Cargando…

The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease

Children with acquired heart disease face significant health challenges, including a lifetime of strict medical management, multiple cardiac surgeries, and a high mortality risk. Though the presentation of these conditions is diverse, a unifying factor is the role of immune and inflammatory response...

Descripción completa

Detalles Bibliográficos
Autores principales: Jui, Elysa, Singampalli, Kavya L., Shani, Kevin, Ning, Yao, Connell, Jennifer P., Birla, Ravi K., Bollyky, Paul L., Caldarone, Christopher A., Keswani, Sundeep G., Grande-Allen, K. Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353076/
https://www.ncbi.nlm.nih.gov/pubmed/34386532
http://dx.doi.org/10.3389/fcvm.2021.701224
_version_ 1783736323563061248
author Jui, Elysa
Singampalli, Kavya L.
Shani, Kevin
Ning, Yao
Connell, Jennifer P.
Birla, Ravi K.
Bollyky, Paul L.
Caldarone, Christopher A.
Keswani, Sundeep G.
Grande-Allen, K. Jane
author_facet Jui, Elysa
Singampalli, Kavya L.
Shani, Kevin
Ning, Yao
Connell, Jennifer P.
Birla, Ravi K.
Bollyky, Paul L.
Caldarone, Christopher A.
Keswani, Sundeep G.
Grande-Allen, K. Jane
author_sort Jui, Elysa
collection PubMed
description Children with acquired heart disease face significant health challenges, including a lifetime of strict medical management, multiple cardiac surgeries, and a high mortality risk. Though the presentation of these conditions is diverse, a unifying factor is the role of immune and inflammatory responses in their development and/or progression. For example, infectious agents have been linked to pediatric cardiovascular disease, leading to a large health burden that disproportionately affects low-income areas. Other implicated mechanisms include antibody targeting of cardiac proteins, infection of cardiac cells, and inflammation-mediated damage to cardiac structures. These changes can alter blood flow patterns, change extracellular matrix composition, and induce cardiac remodeling. Therefore, understanding the relationship between the immune system and cardiovascular disease can inform targeted diagnostic and treatment approaches. In this review, we discuss the current understanding of pediatric immune-associated cardiac diseases, challenges in the field, and areas of research with potential for clinical benefit.
format Online
Article
Text
id pubmed-8353076
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83530762021-08-11 The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease Jui, Elysa Singampalli, Kavya L. Shani, Kevin Ning, Yao Connell, Jennifer P. Birla, Ravi K. Bollyky, Paul L. Caldarone, Christopher A. Keswani, Sundeep G. Grande-Allen, K. Jane Front Cardiovasc Med Cardiovascular Medicine Children with acquired heart disease face significant health challenges, including a lifetime of strict medical management, multiple cardiac surgeries, and a high mortality risk. Though the presentation of these conditions is diverse, a unifying factor is the role of immune and inflammatory responses in their development and/or progression. For example, infectious agents have been linked to pediatric cardiovascular disease, leading to a large health burden that disproportionately affects low-income areas. Other implicated mechanisms include antibody targeting of cardiac proteins, infection of cardiac cells, and inflammation-mediated damage to cardiac structures. These changes can alter blood flow patterns, change extracellular matrix composition, and induce cardiac remodeling. Therefore, understanding the relationship between the immune system and cardiovascular disease can inform targeted diagnostic and treatment approaches. In this review, we discuss the current understanding of pediatric immune-associated cardiac diseases, challenges in the field, and areas of research with potential for clinical benefit. Frontiers Media S.A. 2021-07-27 /pmc/articles/PMC8353076/ /pubmed/34386532 http://dx.doi.org/10.3389/fcvm.2021.701224 Text en Copyright © 2021 Jui, Singampalli, Shani, Ning, Connell, Birla, Bollyky, Caldarone, Keswani and Grande-Allen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Jui, Elysa
Singampalli, Kavya L.
Shani, Kevin
Ning, Yao
Connell, Jennifer P.
Birla, Ravi K.
Bollyky, Paul L.
Caldarone, Christopher A.
Keswani, Sundeep G.
Grande-Allen, K. Jane
The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
title The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
title_full The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
title_fullStr The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
title_full_unstemmed The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
title_short The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
title_sort immune and inflammatory basis of acquired pediatric cardiac disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353076/
https://www.ncbi.nlm.nih.gov/pubmed/34386532
http://dx.doi.org/10.3389/fcvm.2021.701224
work_keys_str_mv AT juielysa theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT singampallikavyal theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT shanikevin theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT ningyao theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT connelljenniferp theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT birlaravik theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT bollykypaull theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT caldaronechristophera theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT keswanisundeepg theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT grandeallenkjane theimmuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT juielysa immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT singampallikavyal immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT shanikevin immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT ningyao immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT connelljenniferp immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT birlaravik immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT bollykypaull immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT caldaronechristophera immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT keswanisundeepg immuneandinflammatorybasisofacquiredpediatriccardiacdisease
AT grandeallenkjane immuneandinflammatorybasisofacquiredpediatriccardiacdisease